Medical Cannabis Demand Rising Globally as U.S. Reclassification Nears

Aurora Cannabis' global medical cannabis business posted record growth, driven by expanding patient access in Europe, Canada, and Australia. The US is expected to approach cannabis reform through medical use first, with a gradual unfolding process. Regulatory expertise and experience across multiple jurisdictions are crucial as medical cannabis markets expand. Consumer cannabis remains a lower-margin segment, prompting companies to prioritize medical-focused strategies. Existing international production and compliance models could be applied if the US medical market opens further.